Novel thermal imaging analysis technique for detecting inflammation in thyroid eye disease

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages 4600-4606

  Di Maria, Costanzo ^a,c   Allen, John ^a,c   Dickinson, Jane ^a   Neoh, Christopher ^a   Perros, Petros ^b  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CHEMOSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENDOCRINE OPHTHALMOPATHY; EYE EXAMINATION; EYE INFLAMMATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING; MALE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TEMPERATURE SENSITIVITY; TERTIARY CARE CENTER; THERMAL IMAGING; ADULT; ALGORITHM; COMPLICATION; EYE; GRAVES OPHTHALMOPATHY; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; TEMPERATURE; THERMOGRAPHY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC IMAGING; EYE; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TEMPERATURE; THERMOGRAPHY; YOUNG ADULT;

EID: 84916624182     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1957     Document Type: Article

References (32)

1. Perros P, Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab. 1995;9:115-135.
2. Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27:259-264.
3. Bahmani-Kashkouli M, Pakdel F, Astaraki A, et al. Quality of life in patients with thyroid eye disease. J Ophthalmic Vis Res. 2009;4:164-168.
4. Abraham-Nordling M, Byström K, Törring O, Lantz M. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011;165:899-905.
5. Dickinson AJ, Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol. 2001;55:283-303.
6. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997;47:9-14.
7. Prummel MF, Suttorp-Schulten MS, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy. Ophthalmology. 1993;100: 556-561.
8. Gerding MN, Prummel MF, Wiersinga WM. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Clin Endocrinol (Oxf). 2000;52:641-646.
9. Char DH, Norman D. The use of computed tomography and ultrasonography in the evaluation of orbital masses. Surv Ophthalmol. 1982;27:49-63.
10. Goodall KL, Jackson A, Leatherbarrow B, Whitehouse RW. Enlargement of the tensor intermuscularis muscle in Graves' ophthalmopathy. A computed tomographic and magnetic resonance imaging study. Arch Ophthalmol. 1995;113:1286-1289.
11. Tachibana S, Murakami T, Noguchi H, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. Endocr J. 2010;57:853-861.
12. Polito E, Leccisotti A. MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response. Ophthalmologica. 1995;209:182-186.
13. Konuk O, Atasever T, Unal M, et al. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment. Thyroid. 2005;15:358-363.
14. Szabados L, Nagy EV, Ujhelyi B, et al. The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy. Nucl Med Commun. 2013;34:108-112.
15. Terwee CB, Prummel MF, Gerding MN, Kahaly GJ, Dekker FW, Wiersinga WM. Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathy. Clin Endocrinol. 2005;62: 145-155.
16. Ring EF, Ammer K. Infrared thermal imaging in medicine. Physiol Meas. 2012;33:R33-R46.
17. Allen J, Howell K. Microvascular imaging: techniques and opportunities for clinical physiological measurements. Physiol Meas. 2014;35:R91-R141.
18. Pauling JD, Shipley JA, Harris ND, McHugh NJ. Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis. Clin Exp Rheumatol. 2012; 30(2 Suppl 71):S103-S115.
19. Anderson KN, Di Maria C, Allen J. Novel assessment of microvascular changes in idiopathic restless legs syndrome (Willis-Ekbom disease). J Sleep Res. 2013;22:315-321.
20. Allen J, Oates CP, Chishti AD, Ahmed IA, Talbot D, Murray A. Thermography and colour duplex ultrasound assessments of arte-rio- venous fistula function in renal patients. Physiol Meas. 2006;27:51-60.
21. th Annual Meeting of the European Thyroid Association, Pisa, Italy, 8-12 September 2012. Eur Thyroid J. 2012;1(suppl 1):123(P65) (Abstract).
22. Shih SR, Li HY, Hsiao YL, Chang TC. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy. Acta Ophthalmol. 2010;88:e154-e159.
23. Chang TC, Hsiao YL, Liao SL. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:45-49.
24. European Group on Graves' Orbitopathy (EUGOGO), Wiersinga WM, Perros P, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006;155:387-389.
25. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73:639-644.
26. Richards RE, Allen J, Howell KJ, Smith RE. Evaluation of three thermal imaging cameras for skin temperature measurement using a blackbody reference source and a spatial resolution test object. Thermology International. 2013;23:17-23.
27. nd ed. New York, NY: John Wiley and Sons; 2000.
28. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3: 32-35.
29. Bewick V, Cheek L, Ball J. Statistics review 8: Qualitative data - test of association. Crit Care. 2004;8:46-53.
30. Bartalena L, Krassas GE, Wiersinga W, et al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab. 2012;97:4454-4463.
31. Khanna D, Chong KK, Afifiyan NF, et al. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology. 2010;117:133-139.e2.
32. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-Rexpression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf). 2003;58:280-287.